Mob/WhasApp:+86-13383307826 丨 E-mail:admin@cnths.com

Semaglutide Powder CAS 910463-68-2 Semaglutide Injections Tirzepatide Melanotan 2 Peptide 10mg 15mg

PRODUCTS > Peptide > Semaglutide Powder CAS 910463-68-2 Semaglutide Injections Tirzepatide Melanotan 2 Peptide 10mg 15mg

Semaglutide Powder CAS 910463-68-2 Semaglutide Injections Tirzepatide Melanotan 2 Peptide 10mg 15mg

Oral 1-2 antidiabetic drugs at the same time. In December 2017, the FDA officially approved the once-a-week GLP-1 hypoglycemic drug semaglutide, a once-a-week GLP-1 hypoglycemic drug developed by Novo Nordisk, under....
Price: 0.00
Prodcut nameSemaglutide
Standard packing materialAluminum foil bag inside, then waterproof bag or carton
AppearanceWhite powder
Purity99%
Storage

Lyophilized peptides although stable at room temperature for 3 months, should be stored 

desiccatedbelow -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. 


Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.Semaglutide This trial investigated the efficacy and safety of 1.0 mg of semaglutide compared with 2.0 mg of exenatide once weekly in 813 patients with type 2 diabetes for a period of 56 weeks. Oral 1-2 antidiabetic drugs at the same time. In December 2017, the FDA officially approved the once-a-week GLP-1 hypoglycemic drug semaglutide, a once-a-week GLP-1 hypoglycemic drug developed by Novo Nordisk, under the trade name Ozempc. According to clinical trial data, Ozempc can reduce HbA1c levels compared to placebo, Merck's Januvia, AstraZeneca's Bydureon and Sanofi's Lantus. The drug has also shown the ability to help patients lose weight

Name
Phone
Email
Corporate name
Address
Leaving Message*
 
Verification code
Submit